Furthermore, moderate concentrations of SFX-01 resulted in an increased G0/G1 cell population in mutant Shp2-expressing JMML patient-derived hematopoietic stem cells (HSCs) compared to those isolated from control cord blood (CB) (Fig. 5E). This evidence concerns the gene PTPN11 and juvenile myelomonocytic leukemia.